Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.6101
-0.0280 (-4.38%)
Feb 20, 2026, 2:35 PM EST - Market open
MTNB Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
3
Market Cap
3.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 1.10M | -2.09M | -65.62% |
| Dec 31, 2022 | 3.19M | 3.16M | 9,560.61% |
| Dec 31, 2021 | 33.00K | -125.33K | -79.16% |
| Dec 31, 2020 | 158.33K | 68.52K | 76.29% |
| Dec 31, 2019 | 89.81K | -29.94K | -25.00% |
| Dec 31, 2018 | 119.75K | -29.94K | -20.00% |
| Dec 31, 2017 | 149.69K | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | 194.49K | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GeoVax Labs | 3.35M |
| 60 Degrees Pharmaceuticals | 1.36M |
| PMGC Holdings | 285.95K |
| Silo Pharma | 72.10K |
| Cardio Diagnostics Holdings | 15.78K |
MTNB News
- 1 year ago - Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors - GlobeNewsWire
- 1 year ago - Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of Directors - GlobeNewsWire
- 1 year ago - Matinas BioPharma Appoints Evelyn D'An to Board of Directors as Audit Committee Chair - GlobeNewsWire
- 1 year ago - Matinas BioPharma Receives NYSE Noncompliance Notice - GlobeNewsWire
- 1 year ago - Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction - GlobeNewsWire
- 1 year ago - Matinas BioPharma Holdings, Inc. (MTNB) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 1 year ago - Matinas BioPharma to Webcast Conference Call to Discuss Second Quarter 2024 Financial Results and Provide a Business Update on August 14, 2024 - GlobeNewsWire